经导管与外科肺动脉瓣置换术后室性心律失常负荷比较
结果显示TC-PVR较S-PVR在术后30天内临床显著VA更少(校正HR 0.20,p=0.002),但中期和晚期风险相似;外科途径、自体右室流出道植入和较大年龄是早期VA的独立预测因素。
要点
- TC-PVR较S-PVR术后30天内临床显著VA风险更低(校正HR 0.20,p=0.002)。
- TC-PVR与S-PVR的中期和晚期VA风险相似。
- 外科途径、自体RVOT植入和较大年龄是早期VA独立预测因素。
核心结论
- 与S-PVR相比,TC-PVR与短期VA负荷降低相关,但中期和晚期VA负荷相当。
主要发现
- TC-PVR较S-PVR术后30天内临床显著VA更少(校正HR 0.20,p=0.002)。
- TC-PVR与S-PVR中期VA风险相似(校正HR 0.72,p=0.62)。
- TC-PVR与S-PVR晚期VA风险相似(校正HR 0.47,p=0.26)。
- 倾向校正模型中,S-PVR、PVR时年龄和自体RVOT(vs 生物瓣/管道流出道)是肺动脉瓣植入后早期VA的独立预测因素(p<0.05)。
临床怎么用
- 对于接受肺动脉瓣置换的先天性心脏病患者,TC-PVR可能减少术后早期临床显著VA,但中期和晚期VA风险与外科途径相当。
- 应关注外科途径、自体RVOT植入及较大年龄等早期VA预测因素,加强术后早期心律监测。
局限性
- 回顾性研究设计。
- 排除了杂交TC-PVR和先天性矫正型大动脉转位患者。
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Comparative ventricular arrhythmia (VA) outcomes following transcatheter (TC-PVR) or surgical pulmonary valve replacement (S-PVR) have not been evaluated. We sought to compare differences in VAs among patients with congenital heart disease (CHD) following TC-PVR or S-PVR. METHODS: Patients with repaired CHD who underwent TC-PVR or S-PVR at the UCLA Medical Center from 2010 to 2016 were analysed retrospectively. Patients who underwent hybrid TC-PVR or had a diagnosis of congenitally corrected transposition of the great arteries were excluded. Patients were screened for a composite of non-intraoperative VA (the primary outcome variable), defined as symptomatic/recurrent non-sustained ventricular tachycardia (VT) requiring therapy, sustained VT or ventricular fibrillation. VA epochs were classified as 0-1 month (short-term), 1-12 months (mid-term) and ≥1 year (late-term). RESULTS: Three hundred and two patients (TC-PVR, n=172 and S-PVR, n=130) were included. TC-PVR relative to S-PVR was associated with fewer clinically significant VAs in the first 30 days after valve implant (adjusted HR 0.20, p=0.002), but similar mid-term and late-term risks (adjusted HR 0.72, p=0.62 and adjusted HR 0.47, p=0.26, respectively). In propensity-adjusted models, S-PVR, patient age at PVR and native right ventricular outflow tract (RVOT) (vs bioprosthetic/conduit outflow tract) were independent predictors of early VA after pulmonary valve implantation (p<0.05 for all). CONCLUSION: Compared with S-PVR, TC-PVR was associated with reduced short-term but comparable mid-term and late-term VA burdens. Risk factors for VA after PVR included a surgical approach, valve implantation into a native RVOT and older age at PVR.
引用
- Wadia SK, Lluri G, Aboulhosn JA, et al. Ventricular arrhythmia burden after transcatheter versus surgical pulmonary valve replacement. Heart. 2018. PMID: 29636402. doi:10.1136/heartjnl-2017-312769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。